vs

Side-by-side financial comparison of KOSS CORP (KOSS) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

KOSS CORP is the larger business by last-quarter revenue ($2.9M vs $2.0M, roughly 1.4× Roivant Sciences Ltd.). KOSS CORP runs the higher net margin — -19.8% vs -13301.2%, a 13281.4% gap on every dollar of revenue. On growth, KOSS CORP posted the faster year-over-year revenue change (-19.6% vs -77.8%). KOSS CORP produced more free cash flow last quarter ($-1.1M vs $-201.4M). Over the past eight quarters, KOSS CORP's revenue compounded faster (4.2% CAGR vs -73.7%).

Koss Corporation is a company in Milwaukee, Wisconsin, US that manufactures headphones. The company created the first high-fidelity stereo headphones in 1958.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

KOSS vs ROIV — Head-to-Head

Bigger by revenue
KOSS
KOSS
1.4× larger
KOSS
$2.9M
$2.0M
ROIV
Growing faster (revenue YoY)
KOSS
KOSS
+58.3% gap
KOSS
-19.6%
-77.8%
ROIV
Higher net margin
KOSS
KOSS
13281.4% more per $
KOSS
-19.8%
-13301.2%
ROIV
More free cash flow
KOSS
KOSS
$200.3M more FCF
KOSS
$-1.1M
$-201.4M
ROIV
Faster 2-yr revenue CAGR
KOSS
KOSS
Annualised
KOSS
4.2%
-73.7%
ROIV

Income Statement — Q2 FY2026 vs Q3 FY2026

Metric
KOSS
KOSS
ROIV
ROIV
Revenue
$2.9M
$2.0M
Net Profit
$-565.4K
$-265.9M
Gross Margin
29.0%
Operating Margin
-35.5%
-16966.1%
Net Margin
-19.8%
-13301.2%
Revenue YoY
-19.6%
-77.8%
Net Profit YoY
-700.6%
-257.0%
EPS (diluted)
$-0.06
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KOSS
KOSS
ROIV
ROIV
Q4 25
$2.9M
$2.0M
Q3 25
$4.1M
$1.6M
Q2 25
$3.1M
$2.2M
Q1 25
$2.8M
$-39.6M
Q4 24
$3.6M
$9.0M
Q3 24
$3.2M
$4.5M
Q2 24
$2.9M
$8.0M
Q1 24
$2.6M
$28.9M
Net Profit
KOSS
KOSS
ROIV
ROIV
Q4 25
$-565.4K
$-265.9M
Q3 25
$243.7K
$-113.5M
Q2 25
$-232.7K
$-223.4M
Q1 25
$-316.7K
$-206.5M
Q4 24
$94.1K
$169.4M
Q3 24
$-419.5K
$-230.2M
Q2 24
$-110.4K
$95.3M
Q1 24
$-313.8K
$-151.1M
Gross Margin
KOSS
KOSS
ROIV
ROIV
Q4 25
29.0%
Q3 25
40.0%
Q2 25
36.0%
Q1 25
39.0%
Q4 24
39.5%
Q3 24
36.6%
Q2 24
40.4%
Q1 24
31.9%
Operating Margin
KOSS
KOSS
ROIV
ROIV
Q4 25
-35.5%
-16966.1%
Q3 25
-1.1%
-19492.9%
Q2 25
-14.2%
-13130.0%
Q1 25
-18.7%
674.8%
Q4 24
-4.0%
-3042.6%
Q3 24
-19.9%
-7636.0%
Q2 24
-11.0%
-1279.5%
Q1 24
-23.1%
-919.5%
Net Margin
KOSS
KOSS
ROIV
ROIV
Q4 25
-19.8%
-13301.2%
Q3 25
6.0%
-7225.9%
Q2 25
-7.5%
-10292.9%
Q1 25
-11.4%
521.8%
Q4 24
2.6%
1878.3%
Q3 24
-13.1%
-5143.8%
Q2 24
-3.8%
1192.7%
Q1 24
-11.9%
-522.3%
EPS (diluted)
KOSS
KOSS
ROIV
ROIV
Q4 25
$-0.06
$-0.38
Q3 25
$0.03
$-0.17
Q2 25
$-0.02
$-0.33
Q1 25
$-0.03
$-0.28
Q4 24
$0.01
$0.23
Q3 24
$-0.05
$-0.31
Q2 24
$-0.01
$0.12
Q1 24
$-0.03
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KOSS
KOSS
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$15.5M
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$30.3M
$4.3B
Total Assets
$36.8M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KOSS
KOSS
ROIV
ROIV
Q4 25
$15.5M
$4.5B
Q3 25
$16.5M
$4.4B
Q2 25
$15.7M
$4.5B
Q1 25
$13.0M
$4.9B
Q4 24
$9.7M
$5.1B
Q3 24
$11.9M
$5.4B
Q2 24
$14.9M
$5.7B
Q1 24
$9.9M
$6.5B
Total Debt
KOSS
KOSS
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
KOSS
KOSS
ROIV
ROIV
Q4 25
$30.3M
$4.3B
Q3 25
$30.9M
$4.4B
Q2 25
$30.6M
$4.3B
Q1 25
$30.7M
$4.7B
Q4 24
$31.0M
$5.2B
Q3 24
$30.8M
$5.2B
Q2 24
$31.1M
$5.4B
Q1 24
$31.1M
$6.0B
Total Assets
KOSS
KOSS
ROIV
ROIV
Q4 25
$36.8M
$5.2B
Q3 25
$37.7M
$5.1B
Q2 25
$37.2M
$5.0B
Q1 25
$37.3M
$5.4B
Q4 24
$37.4M
$5.8B
Q3 24
$38.1M
$6.2B
Q2 24
$37.2M
$6.5B
Q1 24
$37.6M
$7.2B
Debt / Equity
KOSS
KOSS
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KOSS
KOSS
ROIV
ROIV
Operating Cash FlowLast quarter
$-760.8K
$-196.5M
Free Cash FlowOCF − Capex
$-1.1M
$-201.4M
FCF MarginFCF / Revenue
-37.5%
-10076.0%
Capex IntensityCapex / Revenue
10.9%
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-546.7K
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KOSS
KOSS
ROIV
ROIV
Q4 25
$-760.8K
$-196.5M
Q3 25
$762.6K
$-185.7M
Q2 25
$-534.9K
$-204.4M
Q1 25
$370.4K
$-172.6M
Q4 24
$-252.0K
$-207.3M
Q3 24
$201.6K
$-266.8M
Q2 24
$-174.0K
$-192.8M
Q1 24
$328.6K
$-108.5M
Free Cash Flow
KOSS
KOSS
ROIV
ROIV
Q4 25
$-1.1M
$-201.4M
Q3 25
$761.5K
$-193.5M
Q2 25
$-541.8K
$-208.4M
Q1 25
$306.2K
$-173.4M
Q4 24
$-314.3K
$-209.1M
Q3 24
$-155.6K
$-267.8M
Q2 24
$-174.8K
$-193.8M
Q1 24
$269.3K
$-108.8M
FCF Margin
KOSS
KOSS
ROIV
ROIV
Q4 25
-37.5%
-10076.0%
Q3 25
18.7%
-12317.8%
Q2 25
-17.6%
-9604.5%
Q1 25
11.0%
438.1%
Q4 24
-8.8%
-2318.5%
Q3 24
-4.9%
-5984.4%
Q2 24
-6.0%
-2425.5%
Q1 24
10.2%
-376.1%
Capex Intensity
KOSS
KOSS
ROIV
ROIV
Q4 25
10.9%
246.9%
Q3 25
0.0%
499.6%
Q2 25
0.2%
185.9%
Q1 25
2.3%
-2.0%
Q4 24
1.8%
20.3%
Q3 24
11.2%
22.3%
Q2 24
0.0%
12.1%
Q1 24
2.3%
1.2%
Cash Conversion
KOSS
KOSS
ROIV
ROIV
Q4 25
Q3 25
3.13×
Q2 25
Q1 25
Q4 24
-2.68×
-1.22×
Q3 24
Q2 24
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons